Abstract
Linzhou City in northern China has a high incidence of esophageal squamous cell carcinoma (ESCC). This study retrospectively analyzed the data of 231 cases with ESCC collected from 1998 to 2012. Mutations of DNA polymerase β (polβ) gene in the ESCC samples from patients in Linzhou City were examined by amplifying polβ cDNA by RT-PCR followed by cloning and sequencing. Mutations in polβ were found in 105 cases (45.9 %). Nine types of mutations were identified in the polβ cDNA; the most common were 177–234 nt deletion (11.3 %), 462 nt G → T (9.1 %), and 648 nt G → C (6.9 %). Mutations in polβ appeared to be associated with TNM status (P = 0.048). Follow-up data was used for survival analysis. The overall 5-year survival rate of the 231 patients was 37.4 %; the rate for patients with wild-type (WT) polβ was 41.8 %. Compared with the WT polβ group, the median survival for patients with specific mutations (177–234 nt deletion, 462 nt G → T, or 613 nt A → T) was significantly shorter (all P = 0.000), and the 5-year survival rate decreased to 0 %. Patients with the 648 nt G → C mutation had improved survival (P = 0.000) with a 5-year survival rate of 100 %. Our results identified nine types of mutations within polβ cDNA in ESCC patients with four mutations related to patient survival.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10–29.
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80(6):827–41.
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer. 1996;69(3):225–35.
Idriss HT, Al-Assar O, Wilson SH. DNA polymerase beta. Int J Biochem Cell Biol. 2002;34(4):321–4.
Bergoglio V, Pillaire MJ, Lacroix-Triki M, Raynaud-Messina B, Canitrot Y, Bieth A, et al. Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res. 2002;62(12):3511–4.
Canitrot Y, Frechet M, Servant L, Cazaux C, Hoffmann JS. Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J. 1999;13(9):1107–11.
Canitrot Y, Cazaux C, Fréchet M, Bouayadi K, Lesca C, Salles B, et al. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci U S A. 1998;95(21):12586–90.
Sliwinski T, Ziemba P, Morawiec Z, Kowalski M, Zadrozny M, Blasiak J. Polymorphisms of the DNA polymerase beta gene in breast cancer. Breast Cancer Res Treat. 2007;103(2):161–6.
Lang T, Dalal S, Chikova A, DiMaio D, Sweasy JB. The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol Cell Biol. 2007;27(15):5587–96.
Tan XH, Zhao M, Pan KF, Dong Y, Dong B, Feng GJ, et al. Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach. Cancer Lett. 2005;220(1):101–14.
Eydmann ME, Knowles MA. Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer. Cancer Genet Cytogenet. 1997;93(2):167–71.
Dalal S, Hile S, Eckert KA, Sun KW, Starcevic D, Sweasy JB. Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator. Biochemistry. 2005;44(48):15664–73.
Albertella MR, Lau A, O’Connor MJ. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst). 2005;4(5):583–93.
Sobol RW, Foley JF, Nyska A, Davidson MG, Wilson SH. Regulated over-expression of DNA polymerase beta mediates early onset cataract in mice. DNA Repair (Amst). 2003;2(5):609–22.
Khanra K, Panda K, Bhattacharya C, Mitra AK, Sarkar R, Bhattacharyya N. Association of two polymorphisms of DNA polymerase beta in exon-9 and exon-11 with ovarian carcinoma in India. Asian Pac J Cancer Prev. 2012;13(4):1321–4.
Khanra K, Bhattacharya C, Bhattacharyya N. Association of a newly identified variant of DNA polymerase beta (polβΔ63–123, 208–304) with the risk factor of ovarian carcinoma in India. Asian Pac J Cancer Prev. 2012;13(5):1999–2002.
Iwanaga A, Ouchida M, Miyazaki K, Hori K, Mukai T. Functional mutation of DNA polymerase beta found in human gastric cancer–inability of the base excision repair in vitro. Mutat Res. 1999;435(2):121–8.
Zhao GQ, Wang T, Zhao Q, Yang HY, Tan XH, Dong ZM. Mutation of DNA polymerase beta in esophageal carcinoma of different regions. World J Gastroenterol. 2005;11(30):4618–22.
Dong Z, Zhao G, Zhao Q, Yang H, Xue L, Tan X, et al. A study of DNA polymerase beta mutation in human esophageal cancer. Zhonghua Yi Xue Za Zhi. 2002;82(13):899–902.
Dong ZM, Zheng NG, Wu JL, Li SK, Wang YL. Difference in expression level and localization of DNA polymerase beta among human esophageal cancer focus, adjacent and corresponding normal tissues. Dis Esophagus. 2006;19(3):172–6.
Li M, Zang W, Wang Y, Li Y, Ma Y, Wang N, et al. DNA polymerase β promoter mutations and transcriptional activity in esophageal squamous cell carcinoma. Tumour Biol. 2013. doi:10.1007/s13277-013-0898-5.
Wang T, Zang W, Ma Y, Li M, Xuan X, Wang N, et al. DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment. Mol Biol Rep. 2013;40(2):1333–9.
Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17(1):2–9.
Qi YJ, Chao WX, Chiu JF. An overview of esophageal squamous cell carcinoma proteomics. J Proteomics. 2012;75(11):3129–37.
Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. Int J Cancer. 2002;102(3):271–4.
Deziel NC, Wei WQ, Abnet CC, Qiao YL, Sunderland D, Ren JS, et al. A multi-day environmental study of polycyclic aromatic hydrocarbon exposure in a high-risk region for esophageal cancer in China. J Expo Sci Environ Epidemiol. 2013;23(1):52–9.
Cheng KK, Day NE. Nutrition and esophageal cancer. Cancer Causes Control. 1996;7(1):33–40.
Li LW, Li YY, Li XY, Zhang CP, Zhou Y, Lu SH. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma. BMC Cancer. 2011;11:52.
Bhattacharyya N, Banerjee S. A variant of DNA polymerase beta acts as a dominant negative mutant. Proc Natl Acad Sci U S A. 1997;94(19):10324–9.
Guo Z, Zheng L, Dai H, Zhou M, Xu H, Shen B. Human DNA polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity. Nucleic Acids Res. 2009;37(10):3431–41.
Yamtich J, Nemec AA, Keh A, Sweasy JB. A germline polymorphism of DNA polymerase beta induces genomic instability and cellular transformation. PLoS Genet. 2012;8(11):e1003052.
Acknowledgments
This study was supported by a grant from the National Natural Science Foundation of China (no. 81272188).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, M., Zang, W., Wang, Y. et al. DNA polymerase β mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China. Tumor Biol. 35, 553–559 (2014). https://doi.org/10.1007/s13277-013-1077-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-013-1077-4